<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Sabril; Vigabatrin" /><meta name="IX" content="Sabril; Vigabatrin" /><title>Sabril®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP3001-sabril.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP3001-sabril.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP3001-sabril.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 08 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP2092-central-nervous-system.htm">4 Central nervous system</a> &gt; <a href="PHP2897-antiepileptic-drugs.htm">4.8 Antiepileptic drugs</a> &gt; <a href="PHP2898-control-of-the-epilepsies.htm">4.8.1 Control of the epilepsies</a> &gt; <a href="PHP2999-vigabatrin.htm">Vigabatrin</a> &gt; <a href="PHP3000-vigabatrin.htm">VIGABATRIN</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP2999-vigabatrin.htm" title="Previous: Vigabatrin">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP3002-zonisamide.htm" title="Next: Zonisamide">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a310015.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vigabatrin</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Central Nervous System Agents 28:00 &gt; Anticonvulsants 28:12 &gt; Anticonvulsants, Miscellaneous 28:12.92</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/17030-d.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Vigabatrin</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: V &gt; Interactions of Vigabatrin</p></div></li></ul><ul><li><h3>British National Formulary (2)</h3></li><li><a href="PHP2999-vigabatrin.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vigabatrin</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptic drugs &gt; 4.8.1 Control of the epilepsies</p></div></li><li><a href="PHP3000-vigabatrin.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">VIGABATRIN</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptic drugs &gt; 4.8.1 Control of the epilepsies &gt; Vigabatrin</p></div></li></ul><ul><li><h3>BNF for Children (4)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP12441-epilepsy-syndromes.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Epilepsy syndromes</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptics &gt; 4.8.1 Control of the epilepsies</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP12518-vigabatrin.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vigabatrin</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptics &gt; 4.8.1 Control of the epilepsies</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP12519-vigabatrin.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">VIGABATRIN</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptics &gt; 4.8.1 Control of the epilepsies &gt; Vigabatrin</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22vigabatrin%22%22vigabatrin%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/c-d1e1182933.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vigabatrin</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; V</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/17030-d.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vigabatrin</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antiepileptics &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/09978.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vigabatrin</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; V &gt; VI</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-V16.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vigabatrin</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; V</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E2E3E0R0D956.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Vigabatrin</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; V</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c382.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vigabatrin</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; V</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>VIGABATRIN</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int287-vigabatrin.htm">Vigabatrin</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">see <a title="BNF:monograph-family: Vigabatrin" href="PHP2999-vigabatrin.htm">notes above</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">elderly; closely monitor neurological function; avoid sudden withdrawal; history of psychosis, depression, or behavioural problems; absence seizures (may be exacerbated); <strong>interactions:</strong> see   <a title="target-block: Interactions in epilepsy" href="PHP2898-control-of-the-epilepsies.htm#PHP2899">Interactions</a> in section 4.8.1 and Appendix 1 (vigabatrin)</p></div> <div class="cG"><div class="cE"><h3 class="cT">Visual field defects</h3> <p class="cT">Vigabatrin is associated with visual field defects. The onset of symptoms varies from 1 month to several years after starting. In most cases, visual field defects have persisted despite discontinuation, and further deterioration after discontinuation cannot be excluded. Product literature advises visual field testing before treatment and at 6-month intervals. Patients should be warned to report any new visual symptoms that develop and those with symptoms should be referred for an urgent ophthalmological opinion. Gradual withdrawal of vigabatrin should be considered.</p></div></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Contra-indications </h2> <p class="cT">visual field defects</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">consider reduced dose or increased dose interval if eGFR less than 60 mL/minute/1.73 m<sup>2</sup></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">see <a title="BNF:target-block: Pregnancy and breast-feeding in epilepsy" href="PHP2898-control-of-the-epilepsies.htm#PHP2903">Pregnancy</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">see <a title="BNF:target-block: breast-feeding control of epilepsy" href="PHP2898-control-of-the-epilepsies.htm#PHP2904">Breast-feeding</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">nausea, abdominal pain; oedema; drowsiness (<em>rarely</em> encephalopathic symptoms including marked sedation, stupor, and confusion with non-specific slow wave EEG—reduce dose or withdraw), fatigue, excitation (in children), agitation, dizziness, headache, nervousness, depression, aggression, irritability, paranoia, impaired concentration, impaired memory, tremor, paraesthesia, speech disorder, weight gain; visual field defects (see under Cautions), blurred vision, nystagmus, diplopia; <em>less commonly</em> ataxia, psychosis, mania, and rash; occasional increase in seizure frequency (especially if myoclonic); <em>rarely</em> suicidal ideation and retinal disorders (including peripheral retinal neuropathy); <em>very rarely</em> hepatitis, optic neuritis, and optic atrophy; <em>also reported</em> movement disorders in infantile spasms</p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p>With current antiepileptic therapy, initially 1 g daily in single or 2 divided doses then increased according to response in steps of 500 mg at weekly intervals; usual range 2–3 g daily (max. 3 g daily); <span class="cP">child</span> initially 40 mg/kg (body-weight over 25 kg, max. 1 g) daily in single or 2 divided doses, then adjusted according to response; usual maintenance dose, body-weight 10–15 kg, 0.5–1 g daily; body-weight 15–30 kg, 1–1.5 g daily; body-weight 30–50 kg, 1.5–3 g daily; body-weight over 50 kg, 2–3 g daily</p></li> <li><p>Infantile spasms (West's syndrome), <em>monotherapy</em>, 50 mg/kg daily, adjusted according to response over 7 days; up to 150 mg/kg daily used with good tolerability</p></li> </ul></div></div> </div><div id="pS"><p>Sub-sections</p><div id="PHP3001-sabril" style="margin: 0 0 0 20px;"><h1 class="title">Sabril® <span>(<a href="PHP10005-index-of-manufacturers.htm#PHP10320">Sanofi-Aventis</a>)</span><span> <img src="images/pom_l.png" alt="Prescription only medicine" /></span></h1><div class="cU"><p><strong>Tablets</strong>, f/c, scored, vigabatrin 500 mg, net price 100-tab pack = £30.84. Label: 3, 8, counselling, driving (see <a title="target-block: Driving and epilepsy" href="PHP2898-control-of-the-epilepsies.htm#PHP2902">notes above</a>)</p></div><div class="cU"><p><strong>Powder</strong>, sugar-free, vigabatrin 500 mg/sachet. Net price 50-sachet pack = £17.08. Label: 3, 8, 13, counselling, driving (see <a title="target-block: Driving and epilepsy" href="PHP2898-control-of-the-epilepsies.htm#PHP2902">notes above</a>)</p><div class="cG"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">The contents of a sachet should be dissolved in water or a soft drink immediately before taking</p></div></div></div></div></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP2999-vigabatrin.htm">Previous: Vigabatrin</a> | <a class="top" href="PHP3001-sabril.htm#">Top</a> | <a accesskey="]" href="PHP3002-zonisamide.htm">Next: Zonisamide</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>